+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin drug eluting stent (DES) for early stent thrombosis



Statin drug eluting stent (DES) for early stent thrombosis



Atherosclerosis 207(2): 343




(PDF emailed within 0-6 h: $19.90)

Accession: 055911068

Download citation: RISBibTeXText

PMID: 19539291

DOI: 10.1016/j.atherosclerosis.2009.05.026


Related references

Subacute stent thrombosis after drug-eluting stent implantation for treatment of bare metal stent associated very late stent thrombosis. 2007

Subacute stent thrombosis after drug-eluting stent implantation for treatment of bare metal stent associated very late stent thrombosis. Zhonghua Xin Xue Guan Bing Za Zhi 36(2): 175-176, 2009

High plasma interleukin-6 is associated with drug-eluting stent thrombosis: possible role of inflammatory cytokines in the development of stent thrombosis from the Korea Stent Thrombosis Registry. Circulation Journal 75(6): 1350-1357, 2011

The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clinical Research in Cardiology 98(9): 549-554, 2009

Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]). Jacc. Cardiovascular Interventions 5(7): 728-737, 2012

Implantation of a Drug-Eluting Stent With a Different Drug Switch Strategy in Patients With Drug-Eluting Stent Restenosis Results From a Prospective Multicenter Study RIBS III Restenosis Intra-Stent Balloon Angioplasty Versus Drug-Eluting Stent. 2012

Who is at risk to develop late drug-eluting stent thrombosis while on dual antiplatelet therapy? A subset analysis from the Drug Eluting Stent Event Registry of Thrombosis (DESERT). European Heart Journal 34(Suppl 1): P3047-P3047, 2013

Neoatherosclerosis, plaque rupture and very late stent thrombosis of a first generation drug eluting stent treated with aspiration thrombectomy and newer generation drug eluting stent implantation. International Journal of Cardiology 201: 648-649, 2016

A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary arteries. Cardiovascular Diagnosis and Therapy 5(2): 113-121, 2015

Stent underexpansion in early drug-eluting stent thrombosis. Jacc. Cardiovascular Interventions 2(8): 807, 2009

Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation 125(9): 1110-1121, 2012

Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by left ventricular ejection fraction. European Heart Journal 34(Suppl 1): P5484-P5484, 2013

Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF. Heart 101(1): 50-57, 2015

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. European Heart Journal 31(10): 1172-1180, 2011

Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry. Catheterization and Cardiovascular Interventions 81(2): 260-265, 2013